scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1007077236 |
P356 | DOI | 10.1186/1297-9716-44-48 |
P932 | PMC publication ID | 3720265 |
P698 | PubMed publication ID | 23826638 |
P5875 | ResearchGate publication ID | 245536610 |
P50 | author | Hui-Chen Guo | Q120571234 |
Shi-Qi Sun | Q120571445 | ||
P2093 | author name string | Hong Yin | |
Ye Jin | |||
Jian-Xun Luo | |||
Xiang-Tao Liu | |||
Jian-Hong Guo | |||
Jun-Wu Ma | |||
Ding Xiang Liu | |||
Zai-Xin Liu | |||
De-Hui Sun | |||
Yan-Quan Wei | |||
Shuang-Hui Yin | |||
Shun-Li Yang | |||
P2860 | cites work | Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes | Q27860623 |
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution | Q28756233 | ||
SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. | Q30342324 | ||
Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine | Q33338439 | ||
New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines | Q33573531 | ||
Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli | Q33636884 | ||
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. | Q33822639 | ||
Structures of virus and virus-like particles | Q33885190 | ||
Development of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupae | Q34405725 | ||
Foot-and-mouth disease | Q34547126 | ||
Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. | Q35043566 | ||
Control and eradication of foot-and-mouth disease | Q35044863 | ||
Protective immune response against foot-and-mouth disease | Q35226002 | ||
Foot-and-mouth disease: host range and pathogenesis | Q36008121 | ||
An efficient system for high-level expression and easy purification of authentic recombinant proteins | Q36526542 | ||
Virus-like particles: passport to immune recognition | Q36602264 | ||
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome | Q36686327 | ||
The coming of age of virus-like particle vaccines | Q37309265 | ||
Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. | Q37329062 | ||
Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein | Q38328649 | ||
FMD subunit vaccine produced using a silkworm–baculovirus expression system: Protective efficacy against two type Asia1 isolates in cattle | Q39627361 | ||
Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes | Q39704435 | ||
Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep | Q39740005 | ||
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. | Q39869070 | ||
Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. | Q39879004 | ||
Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs | Q39891157 | ||
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus | Q40015542 | ||
Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles. | Q40165012 | ||
Stability and immunogenicity of empty particles of foot-and-mouth disease virus | Q40214915 | ||
Relationship Between Virus Neutralization and Serum Protection Bioassays for IgG and IgM Antibodies to Foot-and-Mouth Disease Virus | Q40218387 | ||
Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. | Q40422822 | ||
Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. | Q40433851 | ||
Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus. | Q40680381 | ||
Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants | Q41060791 | ||
Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins | Q41608082 | ||
Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease | Q41899098 | ||
Co-overexpression of folding modulators improves the solubility of the recombinant guinea pig liver transglutaminase expressed in Escherichia coli | Q44032781 | ||
Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents | Q44659482 | ||
The solubility and stability of recombinant proteins are increased by their fusion to NusA. | Q45035964 | ||
Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency | Q45354442 | ||
Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease | Q45387024 | ||
Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China. | Q45398156 | ||
The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus | Q45564180 | ||
The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells | Q45730227 | ||
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. | Q45733658 | ||
Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system | Q45767549 | ||
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application | Q45835912 | ||
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. | Q45835914 | ||
Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing | Q45845067 | ||
Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites | Q45847241 | ||
High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system. | Q54561263 | ||
Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. | Q55034194 | ||
Rapid protein-folding assay using green fluorescent protein | Q56902199 | ||
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals | Q57103184 | ||
Clinical and laboratory investigations of five outbreaks of foot-and-mouth disease during the 2001 epidemic in the United Kingdom | Q57105118 | ||
In vitro assembly of poliovirus 14 S subunits: Identification of the assembly promoting activity of infected cell extracts | Q67912405 | ||
The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccination | Q72411315 | ||
P921 | main subject | Escherichia coli | Q25419 |
foot-and-mouth disease virus | Q1911079 | ||
foot-and-mouth disease | Q152401 | ||
P304 | page(s) | 48 | |
P577 | publication date | 2013-07-04 | |
P1433 | published in | Veterinary Research | Q15761008 |
P1476 | title | Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle | |
P478 | volume | 44 |
Q42197160 | A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds. |
Q41071634 | A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles |
Q38252451 | Adjuvants for foot-and-mouth disease virus vaccines: recent progress |
Q28537703 | Binding of glutathione to enterovirus capsids is essential for virion morphogenesis |
Q57008195 | Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity |
Q28080092 | Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs |
Q42002998 | Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system. |
Q39063658 | Foot-and-mouth disease vaccines |
Q38694452 | Foot-and-mouth disease vaccines: progress and problems |
Q38208419 | Foot-and-mouth disease: technical and political challenges to eradication. |
Q38851217 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines |
Q59351586 | Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine |
Q102142384 | Green preparation of hydrogel particles-in-emulsions for simultaneous enhancement of humoral and cell-mediated immunity |
Q40156866 | Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV). |
Q36066573 | Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. |
Q45323916 | Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana. |
Q35941324 | Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves |
Q42233344 | Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine |
Q56556960 | Single-domain antibodies as promising experimental tools in imaging and isolation of porcine epidemic diarrhea virus |
Q33812653 | Subviral particle as vaccine and vaccine platform |
Q38603912 | The application of virus-like particles as vaccines and biological vehicles |
Q38265915 | Three-dimensional structure of foot-and-mouth disease virus and its biological functions |
Q38197494 | Virus-like particles in picornavirus vaccine development |
Search more.